Skip to main content
Premium Trial:

Request an Annual Quote

Settlement After DNA Testing Questions

A forensic scientist who was fired after questioning a DNA testing approach used by the Office of Chief Medical Examiner in New York City has been awarded a $1 million settlement, the New York Times reports.

According to the Times, Marina Stajic had directed the toxicology laboratory at the medical examiner's office and was a member of the state forensics panel. As part of the panel, she voted to require the medical examiner's office to release the study it said it did that validated its low copy number DNA testing approach. As the Times notes, another state forensics panel member, criminal defense attorney Barry Scheck, had asked for the study to be released as cases involving such small DNA samples were appearing in the courtroom.

After being fired, Stajic sued and, the Times reports, the city settled with her earlier this week.

Stajic's lawyers argue, though, that the lawsuit indicates the city's medical examiner's office did not perform the validation study it said it did. The ME's office argues that the approach was well tested, the Times adds.

The Scan

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.